Skip to content

Cryotherapy in the Treatment of Desmoid Tumors

Cryotherapy in the Treatment of Desmoid Tumors

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05091255
Enrollment
94
Registered
2021-10-25
Start date
2021-05-20
Completion date
2027-01-01
Last updated
2025-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Desmoid

Keywords

desmoid tumor; cryotherapy

Brief summary

Desmoid tumor is a benign neoplasm with an unpredictable course and a high rate of local recurrence if treated surgically. Therefore, over time the surgical approach has become conservative, preferring simple observation or medical therapy in case of disease progression through the use of hormonal therapy and low-dose chemotherapy. Since this neoplasm remains benign, our study aims to avoid chemotherapy in patients usually young through the use of a minimally invasive treatment such as cryotherapy.

Interventions

PROCEDURECryotherapy

The procedure involves general or peripheral anesthesia and percutaneous treatment under CT control with probes capable of forming ice spheres of up to 3 cm that will be used in sufficient number to treat the neoplasm completely.

Sponsors

Istituto Ortopedico Rizzoli
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* histologic diagnosis of desmoid tumors * age \> 18 years * abdominal and extra-abdominal desmoid tumors

Exclusion criteria

* contraindication to the procedure by the interventional radiologist in terms of tumor proximity to neurologic/vascular structures * retroperitoneal desmoid tumors * age \< 18 years

Design outcomes

Primary

MeasureTime frameDescription
response to treatmentAt baseline (time 0)assessment of tumor response to treatment will be performed using the solid tumor response criteria

Countries

Italy

Contacts

Primary ContactCostantino Errani, MD
costantino.errani@ior.it051-6366

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026